TickerFactsScreenerDevelopers

VERTEX PHARMACEUTICALS INC / MA (VRTX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $210.46M2017: $275.12M2018: $409.54M2019: $547.80M2020: $736.30M2021: $904.20M2022: $1.08B2023: $1.26B2024: $1.53B2025: $1.65B$1.65B
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$1.65B+7.9%
2024$1.53B+21.3%
2023$1.26B+16.8%
2022$1.08B+19.5%
2021$904.20M+22.8%
2020$736.30M+34.4%
2019$547.80M+33.8%
2018$409.54M+48.9%
2017$275.12M+30.7%
2016$210.46M—